
Lupus is never a simple disease, but it can be easy to overlook complicating factors that transform a straightforward presentation into something more complex and challenging. And few factors offer […]
A pair of sessions on Monday will offer attendees an update on new and evolving technologies that have the potential to help rheumatology health professionals manage and treat rheumatic disease […]
All healthcare professionals who work in rheumatology had to start adapting to a new landscape of reporting and documentation on Jan. 1 of this year, when the Medicare Access and […]
An ARHP session on Monday will offer attendees the latest information on new medications, new indications, safety issues, and FDA action on biosimilars over the past year. The session, Pharma […]
Safety is a constant concern in treating rheumatologic diseases, and new data can impact the risk profile and use of accepted treatments from year to year. Monday’s FDA Update on […]
The practicing rheumatologist needs a basic understanding of the scientific principles that underlie autoimmune and inflammatory disorders. However, as both basic and clinical science knowledge grows, incorporating science material into […]
Older adults, for whom mobility is critical to maintain independence, make up a significant percentage of the patients cared for by rheumatologists. Those who lose independence are less likely to […]
It is increasingly recognized that changes in chondrocyte phenotypes play an active role in the response of cartilage to injury and in the pathogenesis of osteoarthritis (OA). The symposium Chondrocytes: […]
A panel will update attendees Monday on various bone-related disease issues, including current and investigational medications for treatment of osteoporosis, pediatric bone disease and its progression into adulthood, and osteonecrosis […]
A session on Monday will explore the effect of rheumatoid arthritis (RA) disease activity on cardiovascular disease (CVD) outcomes in patients with RA. Joan M. Bathon, MD, Professor of Medicine […]